NCT07481188 Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery
| NCT ID | NCT07481188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Trakya University |
| Condition | Hip Fracture |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-03-15 |
| Primary Completion | 2027-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-03-15 with a primary completion date of 2027-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hip fractures are serious injuries that occur mostly in older adults. Many people experience health problems or may die in the months after surgery. Doctors try to identify patients who have a higher risk of poor outcomes as early as possible. Doctors often use the Nottingham Hip Fracture Score (NHFS) to estimate the risk of death after hip fracture surgery. This score uses information such as age and other health conditions. However, it does not fully reflect how physically vulnerable a person may be. Another important concept is frailty. Frailty describes how strong or weak a person's overall health and physical reserve are. In this study, frailty will be measured using the Clinical Frailty Scale (CFS). This scale evaluates a person's level of independence and physical function before the fracture. The purpose of this study is to determine whether measuring frailty can improve the prediction of death after hip fracture surgery. Older adults with hip fractures who undergo surgery will be invited to participate in the study. Researchers plan to include about 200 participants or all eligible patients enrolled within one year, whichever occurs first. Health information that is already collected during routine hospital care will be recorded. Frailty will be assessed when participants are admitted to the hospital. Participants will be followed for 30 days and 90 days after surgery to determine survival status. Researchers will review hospital records and may contact participants or their relatives by phone if needed. The results of this study may help doctors better identify patients at higher risk and improve care planning after hip fracture surgery.
Eligibility Criteria
Inclusion Criteria: * Age 60 years or older * Admission for acute proximal femoral fracture (femoral neck, intertrochanteric, or subtrochanteric fracture) * Surgical treatment for hip fracture * Ability to obtain clinical data required for NHFS and frailty assessment Exclusion Criteria: * Pathological fractures * Periprosthetic fractures * Hip fractures resulting from high-energy trauma or polytrauma * Non-operative treatment * Second hip fracture occurring in the same patient during the study period
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07481188 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Hip Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07481188 currently recruiting?
Yes, NCT07481188 is actively recruiting participants. Contact the research team at trkesref@hotmail.com for enrollment information.
Where is the NCT07481188 trial being conducted?
This trial is being conducted at Edirne, Turkey (Türkiye).
Who is sponsoring the NCT07481188 clinical trial?
NCT07481188 is sponsored by Trakya University. The trial plans to enroll 200 participants.